New gel could stop knee surgery scarring in young athletes
NCT ID NCT07081815
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests a liquid gel called JOCOAT APN-3003 that is applied during knee ACL reconstruction surgery to prevent internal scar tissue (adhesions). It involves 24 athletes aged 15 to 25. The gel is placed at the end of surgery, and researchers will check if it improves safety and recovery compared to past patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- JOCOAT(TM) APN-3003 liquid adhesion barrier device
- What this could lead to
- If it works, this could reduce painful scar tissue after knee surgery, helping patients recover better range of motion and return to activity sooner.
- What could go wrong
- This is a very small early trial with only 24 people, comparing results to past patients rather than a control group. The device may not work better than standard care, and there is a risk of side effects like infection or allergic reaction.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGICAL ADHESIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.